IGF1R and colorectal cancer: In fact, combined blockade of MEK and IGF1R has recently been demonstrated to be a synergistic drug combination across colorectal cancer cell lines59 and reciprocal resistance between IGF1R and EGFR signaling inhibitors has been described in multiple cancer types60.